| Product Code: ETC7486016 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Hong Kong continued to heavily rely on imports of phosphodiesterase (PDE) inhibitors, with top exporters being China, Germany, Austria, India, and the USA. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained very high, indicating a dominant presence of these key exporting countries. However, the industry experienced a decline with a negative Compound Annual Growth Rate (CAGR) of -0.39% from 2020 to 2024. The sharp decrease in growth rate from 2023 to 2024 at -92.75% reflects a challenging year for the PDE inhibitors market in Hong Kong.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Overview |
3.1 Hong Kong Country Macro Economic Indicators |
3.2 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Hong Kong Phosphodiesterase (PDE) Inhibitors Market - Industry Life Cycle |
3.4 Hong Kong Phosphodiesterase (PDE) Inhibitors Market - Porter's Five Forces |
3.5 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of erectile dysfunction in Hong Kong |
4.2.2 Increasing awareness about the benefits of phosphodiesterase (PDE) inhibitors |
4.2.3 Technological advancements in the development of PDE inhibitors |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Hong Kong |
4.3.2 Potential side effects associated with PDE inhibitors |
4.3.3 Pricing pressure due to competition among PDE inhibitor manufacturers |
5 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Trends |
6 Hong Kong Phosphodiesterase (PDE) Inhibitors Market, By Types |
6.1 Hong Kong Phosphodiesterase (PDE) Inhibitors Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Specific, 2021- 2031F |
6.1.4 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Non-Specific, 2021- 2031F |
6.1.5 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Hong Kong Phosphodiesterase (PDE) Inhibitors Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Congestive Heart Failure, 2021- 2031F |
6.2.3 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Erectile Dysfunction, 2021- 2031F |
6.2.4 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Inflammatory Airways Disease, 2021- 2031F |
6.2.5 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Hong Kong Phosphodiesterase (PDE) Inhibitors Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Hong Kong Phosphodiesterase (PDE) Inhibitors Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Hong Kong Phosphodiesterase (PDE) Inhibitors Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Import-Export Trade Statistics |
7.1 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Export to Major Countries |
7.2 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Imports from Major Countries |
8 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Key Performance Indicators |
8.1 Number of prescriptions for PDE inhibitors in Hong Kong |
8.2 Patient adherence rate to PDE inhibitor treatment |
8.3 Rate of new product launches in the PDE inhibitor market |
9 Hong Kong Phosphodiesterase (PDE) Inhibitors Market - Opportunity Assessment |
9.1 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Hong Kong Phosphodiesterase (PDE) Inhibitors Market - Competitive Landscape |
10.1 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Hong Kong Phosphodiesterase (PDE) Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |